Cytoplasmic beta-catenin accumulation as a predictor of hematogenous metastasis in human colorectal cancer.
about
Expression and regulation of CD97 in colorectal carcinoma cell lines and tumor tissuesNOD-Like Receptors: Master Regulators of Inflammation and Cancerβ-catenin overexpression in the nucleus predicts progress disease and unfavourable survival in colorectal cancer: a meta-analysis.Nicotine may promote tongue squamous cell carcinoma progression by activating the Wnt/β-catenin and Wnt/PCP signaling pathways.Survey of molecular profiling during human colon cancer development and progression by immunohistochemical staining on tissue microarray.Suppression Of β-catenin Nuclear Translocation By CGP57380 Decelerates Poor Progression And Potentiates Radiation-Induced Apoptosis in Nasopharyngeal Carcinoma.MACC1 promotes carcinogenesis of colorectal cancer via β-catenin signaling pathway.Detection of oncogenes in the diagnosis of cancers with active oncogenic signaling.Role of CD97(stalk) and CD55 as molecular markers for prognosis and therapy of gastric carcinoma patients.MACC1 down-regulation inhibits proliferation and tumourigenicity of nasopharyngeal carcinoma cells through Akt/β-catenin signaling pathway.Association of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer.Expression of RUNX3 and β-catenin in the carcinogenesis of sporadic colorectal tubular adenoma.Relationship between osteopontin and β-catenin immunohistochemical expression and prognostic parameters of colorectal carcinoma.Specific Inhibition of β-Catenin in Jeko-1 Mantle Cell Lymphoma Cell Line Decreases Proliferation and Induces Apoptosis.Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinomaPositive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer.MICAL2 is a novel human cancer gene controlling mesenchymal to epithelial transition involved in cancer growth and invasion.Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer.Novel role of STRAP in progression and metastasis of colorectal cancer through Wnt/β-catenin signaling.Nuclear beta-catenin expression as a prognostic factor in advanced colorectal carcinoma.β-Catenin Expression Negatively Correlates with WIF1 and Predicts Poor Clinical Outcomes in Patients with Cervical Cancer.Nuclear expression and/or reduced membranous expression of β-catenin correlate with poor prognosis in colorectal carcinoma: A meta-analysis.Prognostic impact of the expression of Wnt-signaling proteins in cervical carcinoma FIGO stage I-IV treated with radiotherapy or chemoradiotherapy.Curcumin inhibits bladder cancer progression via regulation of β-catenin expression.Expression and clinical significance of SALL4 and β-catenin in colorectal cancer.Astrocyte elevated gene-1 interacts with β-catenin and increases migration and invasion of colorectal carcinoma.EBV-encoded LMP1 increases nuclear β-catenin accumulation and its transcriptional activity in nasopharyngeal carcinoma.The intratumoral distribution of nuclear beta-catenin is a prognostic marker in colon cancer.Absolute beta-catenin concentrations in Wnt pathway-stimulated and non-stimulated cells.Expression levels of β-catenin and galectin-3 in meningioma and their effect on brain invasion and recurrence: a tissue microarray studyβ-catenin interaction with NHERF1 and RASSF1A methylation in metastatic colorectal cancer patientsImmunohistochemical study of β-catenin and functionally related molecular markers in tongue squamous cell carcinoma and its correlation with cellular proliferation.Characteristic proteins in the plasma of postoperative colorectal and liver cancer patients with Yin deficiency of liver-kidney syndrome.Identification of a noncanonical function for ribose-5-phosphate isomerase A promotes colorectal cancer formation by stabilizing and activating β-catenin via a novel C-terminal domain.Automated subcellular localization and quantification of protein expression in tissue microarrays.BAG3 promotes chondrosarcoma progression by upregulating the expression of β-catenin.Overexpression of xeroderma pigmentosum group C decreases the chemotherapeutic sensitivity of colorectal carcinoma cells to cisplatin.Altered distribution of beta-catenin and prognostic roles in colorectal carcinogenesis.Inhibitory effects of aesculetin on the proliferation of colon cancer cells by the Wnt/β-catenin signaling pathway.Prognostic significance of the wnt signalling pathway molecules APC, beta-catenin and E-cadherin in colorectal cancer: a tissue microarray-based analysis.
P2860
Q24685247-F2034CA1-E4D3-4796-9D12-E99C97C22AE4Q26865199-F8EFFB7F-926C-4EAA-A289-F70AE4B58CDAQ31118386-A2E162A5-833D-4BCE-A3A5-BDCC2DC978AEQ33684528-0F114C8D-EDA8-465B-81E4-53A6E4F2D398Q33787998-357D42B8-CF8A-4E2E-97D1-216BE35085ADQ33836444-FF80175F-79C4-42F4-8A08-E7BBBC9D8C86Q33977050-12CCA4A0-87A7-4487-9501-0BBCC1797772Q34162584-F34FA3B3-AC58-4CA7-8CEC-FFE4E8ADF64DQ34425723-05041E5A-3AD5-47AB-B325-8F0E27E7AE8CQ34662122-56006D7B-CAA3-4C6C-B66F-D20359EF6F56Q34921255-74DC4C64-C893-42AF-83EA-17321399BDDCQ35119181-0AF1946A-E45B-4AAD-8846-7690AE4F007AQ35406491-0856B9C0-F155-4825-8BE3-FC85085739AEQ36010199-EA150078-4F7A-4235-A79A-BD2C32C9FEF0Q36092648-73E060EC-BB92-4646-90B3-3DB3F1E5F963Q36557311-BF253C8B-2EFA-4BD8-8E71-8C0398006BFCQ36738978-3C956CEB-162B-4314-B461-CC1578776006Q37040827-8FA716DE-2C88-4C03-A1A6-89AA64C77B2CQ37085942-0A8F4F93-BCAD-4951-8497-9F4A5A509745Q37290822-69F30164-BB5C-4FD3-AF04-AB1F0758C49AQ37397014-98FA119D-F5DF-4DD7-9BDF-105427C9057FQ37606108-27493993-4387-491D-B39E-9F5E9B9D998AQ37665239-8C0C3C2B-5321-42A1-B8E5-A237869DE3E7Q38697407-AD21EAA3-B27C-439F-8DA9-325D235BEC57Q38802460-DBD06599-74C4-4AEC-8DDE-B709070F576CQ39376658-6F3D767F-672B-4123-B0AD-0E7549F693D1Q39588984-11744A0B-AF14-4723-8A81-FB1BF00E7053Q39994007-C353B32D-02CA-4D1E-8104-FBA921E4CE46Q40270403-7D51898A-7BD2-4B4E-9B4D-1F31ABCDC6B1Q41514245-6156161D-7643-450B-B655-C5DA745C7FC3Q42315542-A2546793-B9E6-44B7-BCA5-0F581E70F9A8Q42323771-FF7FDF05-DE4A-4B7C-BC7F-F4EA8505C375Q47147755-37ABFA72-23EA-4DBE-844F-08711D1063D5Q47654419-F0136AB5-6FBD-4855-A998-E1662C426C7FQ52030096-106980A7-6CEC-46FC-8C21-DE35B31ED14FQ52684027-F5C38618-C949-45FF-8EE1-5E68028CA149Q52721819-388924C6-8415-496F-981A-8544B055C6BEQ53322844-4ADBF520-ECCF-4AD7-BAB2-905DF2990D11Q54090261-33FDA9B0-0F07-4B9C-9F33-5B6BCF021735Q54442810-81DA44B5-B3F7-4DA8-83DB-AAE870F7CA9D
P2860
Cytoplasmic beta-catenin accumulation as a predictor of hematogenous metastasis in human colorectal cancer.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Cytoplasmic beta-catenin accum ...... is in human colorectal cancer.
@en
type
label
Cytoplasmic beta-catenin accum ...... is in human colorectal cancer.
@en
prefLabel
Cytoplasmic beta-catenin accum ...... is in human colorectal cancer.
@en
P2093
P356
P1433
P1476
Cytoplasmic beta-catenin accum ...... is in human colorectal cancer.
@en
P2093
Hirohashi S
Maruyama K
Nakamura S
P304
P356
10.1159/000012187
P577
2000-11-01T00:00:00Z